73 related articles for article (PubMed ID: 8233267)
1. Oral contraceptives and endometrial cancer.
Jick SS; Walker AM; Jick H
Obstet Gynecol; 1993 Dec; 82(6):931-5. PubMed ID: 8233267
[TBL] [Abstract][Full Text] [Related]
2. Researchers can now investigate long-term effects of OCs on cancer.
Rubin GL; Peterson HB
Contracept Technol Update; 1985 Jan; 6(1):7-12. PubMed ID: 12279918
[TBL] [Abstract][Full Text] [Related]
3. The risk of serious illness among oral contraceptive users: evidence from the RCGP's oral contraceptive study.
Hannaford PC; Kay CR
Br J Gen Pract; 1998 Oct; 48(435):1657-62. PubMed ID: 10071398
[TBL] [Abstract][Full Text] [Related]
4. Progestin and estrogen potency of combination oral contraceptives and endometrial cancer risk.
Maxwell GL; Schildkraut JM; Calingaert B; Risinger JI; Dainty L; Marchbanks PA; Berchuck A; Barrett JC; Rodriguez GC
Gynecol Oncol; 2006 Nov; 103(2):535-40. PubMed ID: 16740300
[TBL] [Abstract][Full Text] [Related]
5. [Possible link between long-term oral contraceptive use and cervical cancer].
Perspect Int Planif Fam; 1987; (Spec No):40-1. PubMed ID: 12269054
[TBL] [Abstract][Full Text] [Related]
6. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
7. Estrogen replacement therapy and endometrial cancer risk: unresolved issues. The Endometrial Cancer Collaborative Group.
Brinton LA; Hoover RN
Obstet Gynecol; 1993 Feb; 81(2):265-71. PubMed ID: 8380913
[TBL] [Abstract][Full Text] [Related]
8. Risk of nonfatal venous thromboembolism with oral contraceptives containing norgestimate or desogestrel compared with oral contraceptives containing levonorgestrel.
Jick SS; Kaye JA; Russmann S; Jick H
Contraception; 2006 Jun; 73(6):566-70. PubMed ID: 16730485
[TBL] [Abstract][Full Text] [Related]
9. Decreased risk of endometrial cancer among oral-contraceptive users.
Kaufman DW; Shapiro S; Slone D; Rosenberg L; Miettinen OS; Stolley PD; Knapp RC; Leavitt T; Watring WG; Rosenshein NB; Lewis JL; Schottenfeld D; Engle RL
N Engl J Med; 1980 Oct; 303(18):1045-7. PubMed ID: 7421893
[TBL] [Abstract][Full Text] [Related]
10. Oral contraceptives and liver cancer. Results of the Multicentre International Liver Tumor Study (MILTS).
Contraception; 1997 Nov; 56(5):275-84. PubMed ID: 9437555
[TBL] [Abstract][Full Text] [Related]
11. The misunderstood pill: thirty years of testing and development have reduced pill's major, minor side effects.
United States. Centers for Disease Control CDC. Advisory Committee on Immunization Practices
Netw Res Triangle Park N C; 1986; 7(4):1-5. PubMed ID: 12341093
[TBL] [Abstract][Full Text] [Related]
12. Oral contraceptives have beneficial effects.
PIACT Prod News; 1982 Aug; 4(2):1, 4. PubMed ID: 12311600
[TBL] [Abstract][Full Text] [Related]
13. Oral contraceptive risks: a realistic appraisal.
Bressler R; Durand JL
Drug Ther (NY); 1979 Oct; 9(10):81-95. PubMed ID: 12279276
[TBL] [Abstract][Full Text] [Related]
14. [Oral contraceptives and cerebral thromboembolism. A Danish case-control study].
Lidegaard O
Ugeskr Laeger; 1993 Nov; 155(44):3538-45. PubMed ID: 8236574
[TBL] [Abstract][Full Text] [Related]
15. The estimated effect of oral contraceptive use on the cumulative risk of epithelial ovarian cancer.
Gross TP; Schlesselman JJ
Obstet Gynecol; 1994 Mar; 83(3):419-24. PubMed ID: 8127536
[TBL] [Abstract][Full Text] [Related]
16. Oral contraceptives, reproductive factors, and risk of colorectal cancer among women in a prospective cohort study.
Lin J; Zhang SM; Cook NR; Manson JE; Buring JE; Lee IM
Am J Epidemiol; 2007 Apr; 165(7):794-801. PubMed ID: 17215381
[TBL] [Abstract][Full Text] [Related]
17. Functional ovarian cysts in relation to the use of monophasic and triphasic oral contraceptives.
Holt VL; Daling JR; McKnight B; Moore D; Stergachis A; Weiss NS
Obstet Gynecol; 1992 Apr; 79(4):529-33. PubMed ID: 1553170
[TBL] [Abstract][Full Text] [Related]
18. OCs and genital tract malignancies.
Herbst AL
Dialogues Contracept; 1994; 4(3):5-7. PubMed ID: 12345575
[TBL] [Abstract][Full Text] [Related]
19. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
[TBL] [Abstract][Full Text] [Related]
20. Oral contraceptive use and other risk factors in relation to HER-2/neu overexpression in breast cancer among young women.
Gammon MD; Hibshoosh H; Terry MB; Bose S; Schoenberg JB; Brinton LA; Bernstein JL; Thompson WD
Cancer Epidemiol Biomarkers Prev; 1999 May; 8(5):413-9. PubMed ID: 10350436
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
